Cargando…

Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients

Tryptophan is an essential dietary amino acid that originates uremic toxins that contribute to end-stage kidney disease (ESKD) patient outcomes. We evaluated serum levels and removal during haemodialysis and haemodiafiltration of tryptophan and tryptophan-derived uremic toxins, indoxyl sulfate (IS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paats, Joosep, Adoberg, Annika, Arund, Jürgen, Dhondt, Annemieke, Fernström, Anders, Fridolin, Ivo, Glorieux, Griet, Leis, Liisi, Luman, Merike, Gonzalez-Parra, Emilio, Perez-Gomez, Vanessa Maria, Pilt, Kristjan, Sanchez-Ospina, Didier, Segelmark, Mårten, Uhlin, Fredrik, Arduan Ortiz, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073230/ https://www.ncbi.nlm.nih.gov/pubmed/32102247 http://dx.doi.org/10.3390/ijms21041522

Ejemplares similares

Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate
por: Adoberg, Annika, et al.
Publicado: (2022)

Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements
por: Paats, Joosep, et al.
Publicado: (2022)

Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate
por: Paats, Joosep, et al.
Publicado: (2021)

Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?
por: Arund, Jürgen, et al.
Publicado: (2016)

Paracetamol Interference in Uric Acid Levels in Uremic Patients Revealed by Monitoring Spent Dialysate
por: Tanner, Risto, et al.
Publicado: (2013)

An Optical Method for Serum Calcium and Phosphorus Level Assessment during Hemodialysis
por: Holmar, Jana, et al.
Publicado: (2015)

4-Pyridoxic Acid in the Spent Dialysate: Contribution to Fluorescence and Optical Monitoring
por: Kalle, Sigrid, et al.
Publicado: (2016)

Haemodiafiltration elicits less platelet activation compared to haemodialysis
por: Becs, Gergely, et al.
Publicado: (2016)

Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
por: Blankestijn, Peter J, et al.
Publicado: (2020)

Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration
por: Santos, Alba, et al.
Publicado: (2020)

Do Only Small Uremic Toxins, Chromophores, Contribute to the Online Dialysis Dose Monitoring by UV Absorbance?
por: Arund, Jürgen, et al.
Publicado: (2012)

Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration
por: Voigt, Manuel, et al.
Publicado: (2019)

Optical Method for Cardiovascular Risk Marker Uric Acid Removal Assessment during Dialysis
por: Holmar, Jana, et al.
Publicado: (2012)

Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study
por: Jean, Guillaume, et al.
Publicado: (2015)

Measuring intradialyser transmembrane and hydrostatic pressures: pitfalls and relevance in haemodialysis and haemodiafiltration
por: Ficheux, Alain, et al.
Publicado: (2019)

High dose haemodialysis and haemodiafiltration parameters and the relationship with advanced vascular calcification
por: Park, Sung Keun, et al.
Publicado: (2020)

Haemodiafiltration and haemodialysis should be reported separately by kidney replacement therapy registries
por: Steinwandel, Ulrich, et al.
Publicado: (2022)

Will another trial CONVINCE nephrologists to adopt high-dose haemodiafiltration over conventional haemodialysis?
por: Mayne, Kaitlin J, et al.
Publicado: (2023)

The effect of natriuretic C-type peptide and its change over time on mortality in patients on haemodialysis or haemodiafiltration
por: de Roij van Zuijdewijn, Camiel L M, et al.
Publicado: (2019)

Deciphering the core elements around haemodialysis therapy
por: Bowry, Sudhir K, et al.
Publicado: (2021)

Race and Place in ESKD
por: Watford, Daniel J., et al.
Publicado: (2020)

Clinical evidence on haemodiafiltration
por: Blankestijn, Peter J, et al.
Publicado: (2018)

Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children – the HDF, heart and height (3H) study
por: Shroff, Rukshana, et al.
Publicado: (2018)

Change in FGF23 concentration over time and its association with all-cause mortality in patients treated with haemodialysis or haemodiafiltration
por: Bouma-de Krijger, Annet, et al.
Publicado: (2020)

Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction
por: van Kruijsdijk, Rob C M, et al.
Publicado: (2022)

Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration
por: Jansz, Thijs Thomas, et al.
Publicado: (2018)

Haemodiafiltration—optimal efficiency and safety
por: Ledebo, Ingrid, et al.
Publicado: (2010)

Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration
por: García-Prieto, Ana, et al.
Publicado: (2018)

Proteomic analysis of plasma proteins of high-flux haemodialysis and on-line haemodiafiltration patients reveals differences in transthyretin levels related with anaemia
por: Martínez-Alonso, Emma, et al.
Publicado: (2020)

Knowledge Requirements and Unmet Needs of Informal Caregivers of Patients with End-Stage Kidney Disease (ESKD) Receiving Haemodialysis: A Narrative Review
por: Matthews, Michael, et al.
Publicado: (2021)

Using the cytokinesis-block micronucleus cytome assay to evaluate chromosomal DNA damage in chronic renal patients undergoing bicarbonate haemodialysis and haemodiafiltration
por: GUIDO, M., et al.
Publicado: (2016)

CONVINCE in the context of existing evidence on haemodiafiltration
por: Vernooij, Robin W M, et al.
Publicado: (2022)

A Novel Physical Fatigue Assessment Method Utilizing Heart Rate Variability and Pulse Arrival Time towards Personalized Feedback with Wearable Sensors
por: Allik, Ardo, et al.
Publicado: (2022)

Pilot study to investigate differences in middle molecules, oxidative stress and markers of peripheral vascular disease in patients treated by high flux haemodialysis and haemodiafiltration
por: Nongnuch, Arkom, et al.
Publicado: (2021)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

Valproic acid overdose and continuous venovenous haemodiafiltration
por: Jacobs, Frédéric M., et al.
Publicado: (2008)

The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes
por: Caskey, Fergus J., et al.
Publicado: (2022)

Ecological momentary assessment of fatigue, sleepiness, and exhaustion in ESKD
por: Abdel-Kader, Khaled, et al.
Publicado: (2014)

Pre-ESKD Nephrology Care and Employment at the Start of Dialysis
por: Awan, Ahmed A., et al.
Publicado: (2020)

Hospitalization Trajectories and Risks of ESKD and Death in Individuals With CKD
por: Srivastava, Anand, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1abo3ab66aostv9qnq1a1ahjq6